Physician

Nazish Ahmad, D.O

According to 2025 Medicare claims, Nazish Ahmad, D.O (NPI: 1609187921) practices medical oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is PALO VERDE HEMATOLOGY ONCOLOGY LTD. (NPI: 1447272372; TIN: 860416050) and primary practice location at 85251-4548.

Ahmad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 484 traditional Medicare patients, billed 263,898 HCPCS/CPT codes, and received $4,469,799 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,052 prescription claims across 349 beneficiaries totaling $5,892,742 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 84 claims. Open Payments data shows 203 records totaling $43,200. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $630,738 to $4,469,799. Similarly, Part D prescription costs have moved sharply higher in recent years, from $136,437 to $5,892,742. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	247	40,948	$630,738
2016	277	69,243	$1,628,190
2017	339	128,535	$2,728,811
2018	363	190,590	$2,937,422
2019	371	210,867	$4,141,866
2020	405	160,743	$3,694,103
2021	418	212,280	$4,075,089
2022	425	258,961	$3,823,798
2023	475	248,886	$4,201,125
2024	484	263,898	$4,469,799

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	307	$136,437
2016	100	480	$213,767
2017	146	1,004	$1,047,676
2018	181	1,307	$1,412,616
2019	194	1,260	$1,415,633
2020	217	1,391	$1,574,354
2021	246	1,348	$2,487,287
2022	239	1,429	$2,611,504
2023	293	1,518	$3,366,113
2024	349	2,052	$5,892,742

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	23	$2,624
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	84	$62,010

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	301	1,277	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	244	446	$92
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	93	440	$91
36415	Insertion of needle into vein for collection of blood sample	311	1,106	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	322	1,716	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	48	1,440	$713,804
Xtandi	Enzalutamide	51	1,530	$677,665
Pomalyst	Pomalidomide	18	504	$437,854
Nubeqa	Darolutamide	24	720	$307,303
Lumakras	Sotorasib	14	420	$294,850

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4199	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix	N	N/R	21	$52,531
B4224	Parenteral nutrition administration kit, per day	N	N/R	21	$4,110
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	21	$4,054
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	21	$1,316

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	203	$43,200	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nazish Ahmad, D.O?

Tedicare shows public-source Medicare data for Nazish Ahmad, D.O (NPI 1609187921), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nazish Ahmad, D.O have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nazish Ahmad, D.O?

Nazish Ahmad, D.O is linked to PALO VERDE HEMATOLOGY ONCOLOGY LTD. (billing NPI 1447272372) in the available physician profile data.

Does Nazish Ahmad, D.O have Open Payments data?

Nazish Ahmad, D.O has 203 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.